SNNAQ — Sienna Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Sienna Biopharmaceuticals Says Public Offering Of 8 Mln Common Shares Priced At $2.50 Per Share
U.S. STOCKS ON THE MOVE-CVS, Southwest Airlines, Garmin
Brief: Sienna Biopharma Announces Proposed Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Apple, Twitter, Coty, Mattel
U.S. STOCKS ON THE MOVE-Twitter, Coty, Mattel, Apple
Sienna Biopharma: Surges as hair removal solution meets study goal
Brief: Sienna Biopharmaceuticals Says Data Showed SNA-001 Met Primary Endpoint Of Non-Inferiority In Hair Reduction
Brief: Sienna Biopharmaceuticals Says Entered First Amendment To Loan And Security Agreement With Silicon Valley Bank
Brief: Sienna Biopharmaceuticals Says Implemented Corporate Restructuring To Focus Co's Resources On SNA-120
Brief: Sienna Biopharmaceuticals-Expects To Report Results From 3 Pivotal Trials With SNA-001 In Late Jan/Early Feb 2019-SEC Filing
U.S. STOCKS ON THE MOVE-AMD, Wynn, Discovery, Twitter
U.S. STOCKS ON THE MOVE-Wynn Resorts, AMD, Discovery, Aphria, Tesaro, Nike, Oil companies
Sienna Biopharma: Tumbles as psoriasis treatment fails mid-stage study
Brief: Sienna Biopharmaceuticals Announces Plans To Initiate Phase 3 Psoriasis Trials In Second Half Of 2019
Brief: Sienna Biopharmaceuticals reports third quarter results
Brief: Sienna Biopharmaceuticals Reports Results from Study of SNA-125 In Psoriasis
Brief: Sienna Biopharmaceuticals May Offer And Sell Shares Of Co's Common Stock Having Offering Price Of Up To $75 Mln
Brief: Sienna Biopharmaceuticals Reports Q2 Loss Per Share Of $1.00
Brief: Sienna Biopharma Files For Mixed Shelf Of Upto $250 Mln